This year we have combined our reporting on corporate responsibility with our environment, health and safety report and are reporting online for the first time. These changes are in response to stakeholder feedback and we hope they will make our report accessible to a wider audience.
Data relates to the calendar year 2004 (except where stated). Environment, data is collected from 83 of our 84 pharmaceutical and consumer manufacturing sites, 4 of our 8 biologicals manufacturing sites and 20 of 24 R&D sites as well as 5 of 6 distribution centres, 4 of the 6 major office locations and 6 of the smaller office and sales locations. Health and safety data covers all our 90 manufacturing sites and 23 R&D sites as well as 6 distribution centres, 6 major office locations and 63 of our smaller offices and sales locations. We include data for sites that were in operation for all or part of the year.
The scope of other data relates to our worldwide operations except where indicated.
The GRI Index shows which elements of the Global Reporting Initiative guidelines are covered in our report or elsewhere on our website.
Corporate Responsibility is a large subject and we cannot cover all relevant information in this report. Further background information on our approach to CR is available at Corporate Responsibility and information on corporate governance is available in our Annual Report.
Back to top